Lista de obras - Ros Eeles - Dominio Público Uruguay

"It's all very well reading the letters in the genome, but it's a long way to being able to write": Men's interpretations of undergoing genetic profiling to determine future risk of prostate cancer

artículo científico publicado en 2014

"Social separation" among women under 40 years of age diagnosed with breast cancer and carrying a BRCA1 or BRCA2 mutation

artículo científico publicado en 2006

497 oral PHASE III PILOT STUDY OF DOSE ESCALATION USING CON-FORMAL RADIOTHERAPY IN PROSTATE CANCER: LONG TERM FOLLOW UP

A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer

artículo científico publicado en 2015

A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry

artículo científico publicado en 2020

A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer

artículo científico publicado en 2015

A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics

artículo científico publicado en 2005

A genetic risk score to guide age-specific, personalized prostate cancer screening

A genetic risk score to personalize prostate cancer screening, applied to population data

scientific article published on 24 June 2020

A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population

artículo científico publicado en 2016

A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk

scientific article published on 29 July 2013

A genome-wide pleiotropy scan for prostate cancer risk

artículo científico publicado en 2014

A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

artículo científico publicado en 2016

A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome

artículo científico publicado en 1992

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

artículo científico publicado en 2010

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

artículo científico publicado en 2014

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

artículo científico publicado en 2012

A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers

artículo científico publicado en 2006

A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

artículo científico publicado en 2012

A paradox: urgent BRCA genetic testing

article

A patient with 17 primary tumours and a germ line mutation in TP53: tumour induction by adjuvant therapy?

artículo científico publicado en 2000

A pilot study of compositional analysis of the breast and estimation of breast mammographic density using three-dimensional T1-weighted magnetic resonance imaging

artículo científico publicado en 2008

A population-based audit of ethnicity and breast cancer risk in one general practice catchment area in North London, UK: implications for practice

scientific article published on 15 September 2007

A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer

scientific article published on 06 January 2009

A review of prostate cancer genome wide association studies (GWAS).

artículo científico publicado en 2018

A review of targeted screening for prostate cancer: introducing the IMPACT study

artículo científico publicado en 2007

A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact

artículo científico publicado en 2011

A robust method for detecting CHK2/RAD53 mutations in genomic DNA.

artículo científico publicado en 2002

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers

artículo científico publicado en 2004

AA9int: SNP interaction pattern search using non-hierarchical additive model set

AIDIT and IMPACT: building research collaborations in targeted prostate cancer screening

artículo científico publicado en 2006

ATM polymorphisms as risk factors for prostate cancer development

artículo científico publicado en 2004

ATM protein overexpression in prostate tumors: possible role in telomere maintenance

artículo científico publicado en 2004

Abstract 4836: Gene and environment interactions of height and selected candidate SNPs in prostate cancer: results from the PRACTICAL consortium

artículo científico publicado en 2013

Abstract CT322: DNA repair defects and antitumor activity with PARP inhibition: TOPARP, a phase II trial of olaparib in metastatic castration resistant prostate cancer

Abstract LB-448: Genome-wide association study identifies new prostate cancer susceptibility loci

artículo científico publicado en 2011

Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.

artículo científico publicado en 2004

Accurate prediction of BRCA1 and BRCA2 heterozygous genotype using expression profiling after induced DNA damage

artículo científico publicado en 2006

Accurate prediction of BRCA1 and BRCA2 heterozygous genotypes using expression profiling of lymphocytes after irradiation-induced DNA damage.

artículo científico publicado en 2008

Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom

artículo científico publicado en 2006

Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial.

artículo científico publicado en 2015

African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer

artículo científico publicado en 2020

Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study

artículo científico publicado en 2016

Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group

artículo científico publicado en 1998

Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation

artículo científico publicado en 1998

Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer

artículo científico publicado en 2017

An assessment of the shared allelic architecture between type II diabetes and prostate cancer

artículo científico publicado en 2013

An audit of screening for familial breast cancer before 50 years in the South Thames Region – have we got it right?

scientific article published on 01 January 2004

An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis

artículo científico publicado en 2015

An improved high throughput heteroduplex mutation detection system for screeningBRCA2 mutations?fluorescent mutation detection (F-MD)

artículo científico publicado en 2001

An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

artículo científico publicado en 2020

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

artículo científico publicado en 2015

Analysis of Li–Fraumeni syndrome and Li–Fraumeni-like families for germline mutations in Bcl10

scientific article published on 01 December 1999

Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk

artículo científico publicado en 2019

Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families

artículo científico publicado en 2012

Analysis of familial male breast cancer for germline mutations in CHEK2

article

Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue

artículo científico publicado en 2015

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

article

Analysis techniques in the presence of non-proportional hazards (PH); application to an ovarian cancer RCT with long-term follow-up.

artículo científico publicado en 2015

Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival

artículo científico publicado en 1999

Apoptosis, ageing and cancer susceptibility.

artículo científico publicado en 2003

Apparent Mendelian inheritance of breast and colorectal cancer: chance, genetic heterogeneity or a new gene?

artículo científico publicado en 2001

Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data

artículo científico publicado en 2017

Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels

artículo científico publicado en 2016

Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study

artículo científico publicado en 2009

Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers

artículo científico publicado en 2020

Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study ⬇️

artículo científico publicado en 2017

Association analyses identify 31 new risk loci for colorectal cancer susceptibility

artículo científico publicado en 2019

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

artículo científico publicado en 2018

Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease

artículo científico publicado en 2013

Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses

artículo científico publicado en 2016

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer

artículo científico publicado en 2012

Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data

artículo científico publicado en 2011

Association between hormonal genetic polymorphisms and early-onset prostate cancer

artículo científico publicado en 2005

Association between leptin receptor gene polymorphisms and early-onset prostate cancer

article

Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck

artículo científico publicado en 2005

Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer

artículo científico publicado en 2002

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

artículo científico publicado en 2019

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

artículo científico publicado en 2012

Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.

artículo científico publicado en 2016

Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis

artículo científico publicado en 2009

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

artículo científico publicado en 2010

Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer

artículo científico publicado en 2008

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation

artículo científico publicado en 2016

Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis

artículo científico publicado en 2011

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia

scientific article published in Nature Communications

Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility

artículo científico publicado en 2019

Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry

scientific article published in Nature Communications

Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

artículo científico publicado en 2019

Author Correction: Large-scale transcriptome-wide association study identifies new prostate cancer risk regions

scientific article published in Nature Communications

Author Correction: The evolutionary history of lethal metastatic prostate cancer

artículo científico publicado en 2020

BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital Collaborators

artículo científico publicado en 1999

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years

artículo científico publicado en 2012

BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial.

artículo científico publicado en 2000

BRCA1, BRCA2 and their possible function in DNA damage response

artículo científico publicado en 1999

BRCA1/2 carriers and endocrine risk modifiers

artículo científico publicado en 1999

BRCA1/2 predictive testing: a study of uptake in two centres

BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trial

article

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

artículo científico publicado en 2011

Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information.

artículo científico publicado en 2003

Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis

artículo científico publicado en 2017

Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers

artículo científico

Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls

artículo científico publicado en 2017

Beyond prostate-specific antigen - future biomarkers for the early detection and management of prostate cancer

artículo científico

Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.

artículo científico publicado en 2007

Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance

artículo científico publicado en 2008

Blood lipids and prostate cancer: a Mendelian randomization analysis

artículo científico publicado en 2016

Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers

artículo científico publicado en 2012

Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

artículo científico publicado en 2012

Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer

artículo científico publicado en 2017

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers

artículo científico publicado en 2001

CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours

artículo científico publicado en 2002

Calcium intake, polymorphisms of the calcium-sensing receptor, and recurrent/aggressive prostate cancer

artículo científico publicado en 2015

Cancer genes - Management of carriers of breast cancer genes who have already developed cancer: the Carrier Clinic Model

article

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

artículo científico publicado en 2013

Cancer risks in BRCA2 mutation carriers

artículo científico publicado en 1999

Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features

artículo científico publicado en 2009

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma.

artículo científico publicado en 1989

Cellular characteristics of nipple aspiration fluid during the menstrual cycle in healthy premenopausal women

artículo científico publicado en 2001

Cervical Spine Fractures in Patients Undergoing Palliative Radiotherapy to the Cervical Spine: Implications for Practice

scientific article published on 11 April 2018

Chemoprevention options for BRCA1 and BRCA2 mutation carriers.

artículo científico publicado en 2000

Childhood predictive genetic testing for Li-Fraumeni syndrome

artículo científico publicado en 2009

Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG

artículo científico publicado en 2011

Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study

artículo científico publicado en 2018

Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study

artículo científico publicado en 2019

Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort

artículo científico publicado en 2013

Clinical outcome and service implications of screening women at increased breast cancer risk from a family history

artículo científico publicado en 2006

Clonal analysis of morphological phenotype in cultured mammary epithelial cells from human milk

article

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2011

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction

artículo científico publicado en 2010

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

artículo científico publicado en 2011

Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk

artículo científico publicado en 2012

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2008

Common genetic variants and modification of penetrance of BRCA2-associated breast cancer

artículo científico publicado en 2010

Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis

artículo científico publicado en 2012

Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity

artículo científico publicado en 2016

Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers

artículo científico publicado en 2011

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

artículo científico publicado en 2014

Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

artículo científico publicado en 2012

Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

scientific article published on 05 August 2009

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

artículo científico publicado en 2011

Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness

article

Communicating genetics research results to families: problems arising when the patient participant is deceased

article

Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems

artículo científico publicado en 2005

Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics

artículo científico publicado en 2007

Complex patterns of ETS gene alteration arise during cancer development in the human prostate

artículo científico publicado en 2007

Comprehensive functional annotation of 77 prostate cancer risk loci

artículo científico publicado en 2014

Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings

article

Construction of tissue microarrays from prostate needle biopsy specimens.

artículo científico publicado en 2005

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2020

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

scholarly article by Mia M Gaudet published in November 2010

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer.

artículo científico publicado en 2010

Correction: Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease

artículo científico publicado en 2019

Corrigendum to "Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study" [Eur Urol 2014;66:489-99].

artículo científico publicado en 2014

Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

artículo científico publicado en 2016

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer

artículo científico publicado en 2006

Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy?

artículo científico publicado en 1994

Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer

artículo científico publicado en 2015

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations

artículo científico publicado en 2016

DESNT: A Poor Prognosis Category of Human Prostate Cancer.

artículo científico publicado en 2017

DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer ⬇️

artículo científico publicado en 2015

Delivering cancer genetics services--new ways of working.

artículo científico publicado en 2007

Delivery of cancer genetics services: The Royal Marsden telephone clinic model

article

Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays

artículo científico publicado en 2007

Detection of point mutations in the p53 gene: Comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques

article

Developments in Clinical Practice: Follow up Clinic for BRCA Mutation Carriers: a Case Study Highlighting the "Virtual Clinic".

artículo científico publicado en 2004

Developments in the study of familial breast cancer

Diagnosis and Management of Hereditary Carcinoids.

artículo científico publicado en 2016

Diagnostic radiation procedures and risk of prostate cancer

artículo científico publicado en 2008

Dietary fat and early-onset prostate cancer risk

artículo científico publicado en 2010

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined

artículo científico publicado en 2012

Diffusion-weighted MRI for detecting prostate tumour in men at increased genetic risk. ⬇️

artículo científico publicado en 2014

Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives.

artículo científico publicado en 2007

Diversity of TMPRSS2-ERG fusion transcripts in the human prostate

scientific article published on 16 October 2006

Does Magnetic Resonance Imaging of the Spine Have a Role in the Staging of Prostate Cancer?

artículo científico publicado en 2008

Does genetic counseling have any impact on management of breast cancer risk?

artículo científico publicado en 2005

Dramatic Response to Platinum in a Patient with Cancer with a Germline BRCA2 Mutation

article

Ductal approaches to assessment and management of women at high risk for developing breast cancer

artículo científico publicado en 2004

ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes

artículo científico publicado en 2011

Early outcomes of active surveillance for localized prostate cancer

artículo científico publicado en 2005

Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer.

artículo científico publicado en 2014

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

article by Timothy R. Rebbeck et al published November 2005 in Journal of Clinical Oncology

Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital

artículo científico publicado en 2017

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

artículo científico publicado en 2012

Elevated expression of Ki-67 identifies aggressive prostate cancers but does not distinguish BRCA1 or BRCA2 mutation carriers

scientific article published on 01 February 2010

Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS Study

artículo científico publicado en 2009

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

artículo científico publicado en 2013

Erratum to: MRI breast screening in high-risk women: cancer detection and survival analysis

scholarly article published in Breast Cancer Research and Treatment

Erratum: Corrigendum: Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue

scholarly article by Colin S Cooper et al published June 2015 in Nature Genetics

Erratum: Identification of the breast cancer susceptibility gene BRCA2

artículo científico publicado en 1996

Evaluating genetic risk for prostate cancer among Japanese and Latinos

artículo científico publicado en 2012

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2017

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).

artículo científico publicado en 2009

Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies

artículo científico publicado en 2010

Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium

artículo científico publicado en 2002

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2.

artículo científico publicado en 2011

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers

artículo científico publicado en 2010

Exploring the link between MORF4L1 and risk of breast cancer

artículo científico publicado en 2011

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).

artículo científico publicado en 2012

Expression of Bcl-2, p53, and MDM2 in localized prostate cancer with respect to the outcome of radical radiotherapy dose escalation

artículo científico publicado en 2010

FRMD6 has tumor suppressor functions in prostate cancer

artículo científico publicado en 2020

Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling

artículo científico publicado en 1996

Familial cancer syndromes

artículo científico publicado en 1994

Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study

artículo científico publicado en 1997

Family history of breast cancer: what do women understand and recall about their genetic risk?

artículo científico publicado en 1998

Family stories and the use of heuristics: women from suspected hereditary breast and ovarian cancer (HBOC) families.

artículo científico publicado en 2003

Feasibility of familial PSA screening: psychosocial issues and screening adherence

artículo científico publicado en 2006

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2016

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression

artículo científico publicado en 2013

Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.

artículo científico publicado en 2013

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

artículo científico publicado en 2018

Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer

artículo científico publicado en 2014

Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer

artículo científico publicado en 2014

Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease

scientific article published on 20 February 2014

Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells

artículo científico publicado en 2015

Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2000

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

artículo científico publicado en 2016

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

artículo científico publicado en 2018

Gene expression profiling after radiation-induced DNA damage is strongly predictive of BRCA1 mutation carrier status

artículo científico publicado en 2004

Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls

artículo científico publicado en 2007

Gene-gene interactions in breast cancer susceptibility

artículo científico publicado en 2011

Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).

artículo científico publicado en 2007

Generalizability of established prostate cancer risk variants in men of African ancestry

artículo científico publicado en 2014

Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) C

scientific article published on 26 October 2018

Genetic Testing for Women Previously Diagnosed with Breast/Ovarian Cancer: Examining the Impact of BRCA1 and BRCA2 Mutation Searching

article by N. Hallowell et al published June 2002 in Genetic Testing and Molecular Biomarkers

Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium

artículo científico publicado en 2017

Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study

artículo científico publicado en 2015

Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression

artículo científico publicado en 1995

Genetic predisposition to cancer: the consequences of a delayed diagnosis of Gorlin syndrome

artículo científico publicado en 2005

Genetic predisposition to prostate cancer

artículo científico publicado en 1999

Genetic predisposition to prostate cancer.

artículo científico publicado en 2016

Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines

article

Genetic testing for breast and ovarian cancer predisposition: cancer burden and responsibility

artículo científico publicado en 2002

Genetic testing for cancer predisposition – an ongoing debate

scientific article published on 01 October 2000

Genetic testing in breast/ovarian cancer (BRCA1) families

scientific article published in The Lancet

Genetic variants associated with predisposition to prostate cancer and potential clinical implications

artículo científico publicado en 2012

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies

scientific journal article

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

artículo científico publicado en 2016

Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.

artículo científico publicado en 2016

Genome-wide association studies in cancer.

artículo científico publicado en 2008

Genome-wide association study identifies new prostate cancer susceptibility loci

scientific journal article

Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia. ⬇️

artículo científico publicado en 2018

Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma

artículo científico publicado en 2018

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

artículo científico publicado en 2013

Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility

artículo científico publicado en 2017

Genome-wide association study of prostate cancer-specific survival

artículo científico publicado en 2015

Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses

artículo científico publicado en 2010

Genotype phenotype correlation in Li-Fraumeni syndrome kindreds and its implications for management.

artículo científico publicado en 2006

Germ-Line Mutations in Mismatch Repair Genes Associated with Prostate Cancer

article

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study ⬇️

artículo científico publicado en 2018

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer

artículo científico publicado en 2013

Germline BRCA1 mutations increase prostate cancer risk

artículo científico publicado en 2012

Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel

scientific article published on 15 February 2019

Germline PTEN mutations in Cowden syndrome-like families.

artículo científico publicado en 1998

Germline genetic profiling in prostate cancer: latest developments and potential clinical applications.

scientific article published on 18 December 2015

Germline genetic variants associated with prostate cancer and potential relevance to clinical practice.

artículo científico publicado en 2014

Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT

scientific article published on 27 November 2019

Germline mutations in RAD51D confer susceptibility to ovarian cancer

artículo científico publicado en 2011

Germline mutations in fumarate hydratase (FH) do not predispose to prostate cancer

artículo científico publicado en 2003

Germline mutations in the TP53 gene

artículo científico publicado en 1995

Germline sequencing DNA repair genes in 5,545 men with aggressive and non-aggressive prostate cancer

artículo científico publicado en 2020

Germline variation at 8q24 and prostate cancer risk in men of European ancestry

artículo científico publicado en 2018

Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent

artículo científico publicado en 2013

Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers

artículo científico publicado en 2008

Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1/2 mutations within their family.

artículo científico publicado en 2006

HES5 silencing is an early and recurrent change in prostate tumourigenesis

artículo científico publicado en 2015

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).

artículo científico publicado en 2012

HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease

artículo científico publicado en 2002

Hand pattern indicates prostate cancer risk

artículo científico publicado en 2010

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2011

Head and neck sarcomas: prognostic factors and implications for treatment.

artículo científico publicado en 1993

Healthy women from suspected hereditary breast and ovarian cancer families: the significant others in their lives

artículo científico publicado en 2004

Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

artículo científico publicado en 2019

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium

artículo científico publicado en 2017

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium

article by Artitaya Lophatananon et al published 20 March 2018 in British Journal of Cancer

Hereditary cancer

artículo científico publicado en 2000

Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort

artículo científico publicado en 2014

High burden of copy number alterations andc-MYCamplification in prostate cancer fromBRCA2germline mutation carriers

scholarly article by Elena Castro et al published 7 September 2015 in Annals of Oncology

High risk genes predisposing to prostate cancer development—do they exist?

Homeobox B13 G84E Mutation and Prostate Cancer Risk

artículo científico publicado en 2018

Hormone replacement therapy and survival after surgery for ovarian cancer

artículo científico publicado en 1991

IMPACT Study: Targeted Prostate Cancer Screening

artículo científico publicado en 2013

IMPACT and AIDIT: Strengthening Research Ties in Eastern Europe

artículo científico publicado en 2006

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

artículo científico publicado en 2017

Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor ⬇️

artículo científico publicado en 2017

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

artículo científico publicado en 2013

Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in Over 140,000 European Descendants

scientific article published on 17 May 2019

Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript

artículo científico publicado en 2011

Identification of four new susceptibility loci for testicular germ cell tumour ⬇️

artículo científico publicado en 2015

Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

scientific article published in Nature Communications

Identification of new genetic risk factors for prostate cancer

artículo científico publicado en 2008

Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14

artículo científico publicado en 2013

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

artículo científico publicado en 2009

Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions

artículo científico publicado en 2015

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

artículo científico publicado en 2015

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

artículo científico publicado en 2017

Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study Collaborators.

artículo científico

Implementing molecular characterisation of prostate cancer tissue from patients recruited to the multi-centre STAMPEDE trial: The STRATOSPHERE consortium

artículo científico publicado en 2018

Implications for cancer genetics practice of pro-actively assessing family history in a General Practice cohort in North West London

artículo científico publicado en 2012

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis

artículo científico publicado en 2015

Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers

artículo científico publicado en 2006

Increasing evidence that germline mutations inCHEK2 do not cause Li-Fraumeni syndrome

article

Influence of cytokine gene polymorphisms on the development of prostate cancer

article

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

scientific article published on 06 July 2016

Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer

artículo científico publicado en 2008

Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions

artículo científico publicado en 2015

Intensity-modulated Radiotherapy Allows Escalation of the Radiation Dose to the Pelvic Lymph Nodes in Patients with Locally Advanced Prostate Cancer: Preliminary Results of a Phase I Dose Escalation Study

article by T. Guerrero Urbano et al published April 2010 in Clinical Oncology

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

artículo científico publicado en 2019

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

artículo científico publicado en 1998

Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer

artículo científico publicado en 2011

Intracardiac metastases from germ cell tumours—an unusual but important site of metastasis

Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study

artículo científico publicado en 2008

Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis

artículo científico publicado en 2016

Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals' perspectives

artículo científico publicado en 2010

Large-scale Analysis Demonstrates Familial Testicular Cancer to have Polygenic Aetiology

artículo científico publicado en 2018

Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair

artículo científico publicado en 2015

Large-scale transcriptome-wide association study identifies new prostate cancer risk regions

artículo científico publicado en 2018

Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom.

artículo científico publicado en 2006

Lhermitte's sign as a complication of cisplatin-containing chemotherapy for testicular cancer

artículo científico publicado en 1986

Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype

artículo científico publicado en 2003

Li-Fraumeni syndrome: cancer risk assessment and clinical management

artículo científico

Limb function following conservation treatment of adult soft tissue sarcoma

article

Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators

artículo científico publicado en 1998

Localization of the gene for Cowden disease to chromosome 10q22–23

article

LocusExplorer: a user-friendly tool for integrated visualization of human genetic association data and biological annotations

artículo científico publicado en 2015

Loss of heterozygosity at the BRCA1 and BRCA2 loci detected in ductal lavage fluid from BRCA gene mutation carriers and controls.

artículo científico publicado en 2006

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

artículo científico publicado en 2002

Lymphocyte radiosensitivity inBRCA1 andBRCA2 mutation carriers and implications for breast cancer susceptibility

Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status

artículo científico publicado en 2014

MRI breast screening in high-risk women: cancer detection and survival analysis

artículo científico publicado en 2014

Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer

artículo científico publicado en 2005

Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group

artículo científico publicado en 2000

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.

artículo científico publicado en 2016

Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

artículo científico publicado en 2006

Management of Breast Cancer in BRCA1/2 Mutation Carriers

artículo científico publicado en 1999

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

artículo científico publicado en 2020

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

artículo científico publicado en 2017

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

artículo científico publicado en 2016

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.

artículo científico publicado en 2015

Men with a susceptibility to prostate cancer and the role of genetic based screening.

artículo científico publicado en 2018

Men's decision-making about predictive BRCA1/2 testing: the role of family.

artículo científico publicado en 2005

Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

scientific article published on 19 June 2019

Mimics of metastases from testicular tumours

artículo científico publicado en 1990

Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

artículo científico publicado en 2014

Molecular markers for predicting prostate cancer stage and survival

artículo científico publicado en 2000

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

artículo científico publicado en 2006

Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer

artículo científico publicado en 2013

Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25 ⬇️

artículo científico publicado en 2014

Multicentric breast cancer: clonality and prognostic studies.

artículo científico publicado en 2010

Multiple loci on 8q24 associated with prostate cancer susceptibility

artículo científico publicado en 2009

Multiple loci with different cancer specificities within the 8q24 gene desert

artículo científico publicado en 2008

Multiple newly identified loci associated with prostate cancer susceptibility

artículo científico publicado en 2008

Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium

artículo científico publicado en 2008

Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans

artículo científico publicado en 2015

Mutation analysis of the MSMB gene in familial prostate cancer

artículo científico publicado en 2009

Mutation and association analysis of GEN1 in breast cancer susceptibility

artículo científico publicado en 2010

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation

artículo científico publicado en 1998

Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations

artículo científico publicado en 2018

Mutational signatures of ionizing radiation in second malignancies

artículo científico publicado en 2016

Mutations in BRCA1 and BRCA2 and predisposition to prostate cancer

artículo científico publicado en 2003

National Cancer Institute Prostate Cancer Genetics Workshop

artículo científico publicado en 2011

No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study

scientific article published on 04 June 2008

No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families

artículo científico publicado en 1992

No evidence of germline PTEN mutations in familial prostate cancer

artículo científico publicado en 2000

No evidence that GATA3 rs570613 SNP modifies breast cancer risk

scientific article published on 11 December 2008

No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours.

artículo científico publicado en 2001

No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group

artículo científico publicado en 1997

Non-Hodgkin's lymphoma presenting with extradural spinal cord compression: functional outcome and survival

artículo científico publicado en 1991

Non-Uptake of Predictive Genetic Testing for BRCA1/2 among Relatives of Known Carriers: Attributes, Cancer Worry, and Barriers to Testing in a Multicenter Clinical Cohort

scientific article published on 01 January 2004

Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers

artículo científico publicado en 2010

Optimal age to start preventive measures in women withBRCA1/2mutations or high familial breast cancer risk

artículo científico publicado en 2013

Optimizing the diagnosis of prostate cancer in high-risk men: the supplementary biomarker approach

artículo científico publicado en 2005

Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study

artículo científico publicado en 2018

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group

artículo científico publicado en 2007

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

artículo científico publicado en 2014

Outcome of early detection and radiotherapy for occult spinal cord compression

article

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

Overexpression of RAD51 occurs in aggressive prostatic cancer

artículo científico publicado en 2009

Ownership of uncertainty: healthcare professionals counseling and treating women from hereditary breast and ovarian cancer families who receive an inconclusive BRCA1/2 genetic test result

artículo científico publicado en 2011

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

artículo científico publicado en 2016

Patterns of recurrence after prostate bed radiotherapy

scientific article published on 25 September 2019

Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer.

artículo científico publicado en 2017

Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects

artículo científico publicado en 2005

Phase III trial of conformal radiotherapy following neoadjuvant hormone treatment in early prostate cancer

Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.

artículo científico publicado en 2005

Ploidy and proliferative index in medulloblastoma: useful prognostic factors?

artículo científico publicado en 1993

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts

artículo científico publicado en 2018

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

artículo científico publicado en 2020

Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study

artículo científico publicado en 2019

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening

artículo científico publicado en 2011

Polyglutamine repeat length in theAIB1 gene modifies breast cancer susceptibility inBRCA1 carriers

article

Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.

artículo científico publicado en 2014

Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium

artículo científico publicado en 2016

Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2009

Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics

artículo científico publicado en 2006

Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing Studies

artículo científico publicado en 2016

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics

artículo científico publicado en 2008

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

artículo científico publicado en 2017

Prediction of individual genetic risk to prostate cancer using a polygenic score

artículo científico publicado en 2015

Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up

artículo científico publicado en 2007

Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort

artículo científico publicado en 2002

Predictive testing for germline mutations in the p53 gene: are all the questions answered?

artículo científico publicado en 1993

Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes

artículo científico publicado en 2015

Prevention and early detection of prostate cancer

artículo científico publicado en 2014

Primary fibroblasts from BRCA1 heterozygotes display an abnormal G1/S cell cycle checkpoint following UVA irradiation but show normal levels of micronuclei following oxidative stress or mitomycin C treatment

artículo científico publicado en 2004

Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique.

artículo científico publicado en 2005

Progress in prostate cancer

scholarly article by Lisa Cannon-Albright & Rosalind Eeles published April 1995 in Nature Genetics

Prophylactic mastectomy for genetic predisposition to breast cancer: The Proband's story

artículo científico publicado en 1996

Prostate Cancer Germline Variations and Implications for Screening and Treatment

artículo científico publicado en 2017

Prostate Cancer Risk by BRCA2 Genomic Regions

artículo científico publicado en 2020

Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study

scientific article published on 06 September 2019

Prostate cancer

artículo científico publicado en 2015

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

artículo científico publicado en 2010

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

artículo científico publicado en 2008

Prostate cancer patients' support and psychological care needs: Survey from a non-surgical oncology clinic

artículo científico publicado en 2003

Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status

artículo científico publicado en 2016

Prostate cancer screening in BRCA and Lynch syndrome mutation carriers

artículo científico

Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies

article

Prostate-specific antigen in nipple aspiration fluid: menstrual cycle variability and correlation with serum prostate-specific antigen

artículo científico publicado en 2002

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

artículo científico publicado en 2018

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.

artículo científico publicado en 2018

Proteomic analysis of nipple aspirate fluid throughout the menstrual cycle in healthy pre-menopausal women

artículo científico publicado en 2006

Proteomics and urine analysis: a potential promising new tool in urology

article

Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer

artículo científico publicado en 2000

Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS Study.

artículo científico publicado en 2011

Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY)

scientific article published on 12 November 2019

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort

artículo científico publicado en 2004

Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations

artículo científico publicado en 2018

Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?

artículo científico publicado en 2017

Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort

artículo científico publicado en 2016

Publisher Correction: Shared heritability and functional enrichment across six solid cancers

scientific article published on 23 September 2019

Quantifying the Genetic Correlation between Multiple Cancer Types

artículo científico

RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer

artículo científico publicado en 2017

REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants

artículo científico publicado en 2016

Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy

article

Radiogenomics: radiobiology enters the era of big data and team science

artículo científico publicado en 2014

Radiotherapy and genetic predisposition to breast cancer.

artículo científico publicado en 2006

Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-up

artículo científico publicado en 2013

Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.

artículo científico publicado en 2007

Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activation

artículo científico publicado en 2006

Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease

article

Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer

artículo científico publicado en 2000

Reducing GWAS Complexity

artículo científico publicado en 2016

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC.

artículo científico publicado en 2015

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

artículo científico publicado en 2014

Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer

artículo científico publicado en 2001

Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia

artículo científico publicado en 2002

Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study

scientific article published on 17 September 2020

Reply to S. Kilickap et al, Y. Karakas et al, and I.A. Voutsadakis

artículo científico publicado en 2016

Reply to Xiaoling Lin, Brian T. Helfand, and Jianfeng Xu's Letter to the Editor re: Daniel A. Leongamornlert, Edward J. Saunders, Sarah Wakerell, et al. Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for

scientific article published on 22 June 2019

Reply: ‘Hand pattern indicates risk of prostate cancer’

article by A A Rahman et al published July 2011 in British Journal of Cancer

Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study

artículo científico publicado en 2009

Reproductive decision-making in young female carriers of a BRCA mutation

artículo científico publicado en 2013

Risk Analysis of Prostate Cancer in PRACTICAL Consortium--Response

artículo científico publicado en 2016

Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

artículo científico publicado en 2015

Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer

artículo científico publicado en 1999

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study

artículo científico publicado en 2008

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

scientific article published on 16 January 2020

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2017

Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study.

artículo científico publicado en 2018

Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men.

artículo científico publicado en 2013

Runs of homozygosity and testicular cancer risk

scientific article published on 01 July 2019

SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns

artículo científico publicado en 2017

SNPs in the kallikrein gene region associated with prostate cancer risk: true cause or association by design?

artículo científico publicado en 2008

Salvage radiotherapy in recurrent Hodgkin's disease

artículo científico publicado en 1992

Screening for hereditary cancer and genetic testing, epitomized by breast cancer.

artículo científico publicado en 1999

Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests.

artículo científico publicado en 2011

Screening for prostate cancer: the way ahead

artículo científico publicado en 2010

Screening hCHK2 for Mutations

artículo científico publicado en 2000

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

artículo científico publicado en 2005

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder

artículo científico publicado en 2016

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder.

artículo científico publicado en 2015

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.

artículo científico publicado en 2018

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

artículo científico publicado en 2011

Sexual activity and prostate cancer risk in men diagnosed at a younger age

artículo científico publicado en 2009

Shared common variants in prostate cancer and blood lipids

artículo científico publicado en 2014

Shared heritability and functional enrichment across six solid cancers

artículo científico publicado en 2019

Shared heritability and functional enrichment across six solid cancers

Short report. The AIDIT and IMPACT conference 2006: Outcomes and future directions

artículo científico publicado en 2007

Simultaneous breast cancer in non-identical Ashkenazi Jewish twins: management dilemmas when genetic testing is negative

Spatial genomic heterogeneity within localized, multifocal prostate cancer

artículo científico publicado en 2015

Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer

artículo científico publicado en 2014

Stereotactic body radiotherapy for oligometastases.

artículo científico publicado en 2013

Stratified cancer screening: the practicalities of implementation

artículo científico

Suggestive evidence for a site specific prostate cancer gene on chromosome 1p36. The CRC/BPG UK Familial Prostate Cancer Study Coordinators and Collaborators. The EU Biomed Collaborators

artículo científico publicado en 2000

Surveillance and treatment of malignancy in Bloom syndrome

artículo científico publicado en 2008

Sweat-gland tumours: a clinical review of cases in one centre over 20 years

artículo científico publicado en 2006

TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer.

artículo científico publicado en 2008

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study

artículo científico publicado en 2014

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

artículo científico publicado en 2010

Telomere length shows no association with BRCA1 and BRCA2 mutation status

scientific article published on 29 January 2014

Telomere structure and maintenance gene variants and risk of five cancer types

artículo científico publicado en 2016

Testing for the breast cancer predisposition gene, BRCA1.

artículo científico publicado en 1996

The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

artículo científico publicado en 2020

The G67E mutation in hMLH1 is associated with an unusual presentation of Lynch syndrome

artículo científico publicado en 2009

The IARC TP53 database: new online mutation analysis and recommendations to users

artículo científico publicado en 2002

The New Genomics Era: Integration of genomics into mainstream oncology and implications for psycho-oncological care

scientific article published on 03 February 2020

The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers

artículo científico publicado en 2016

The PCR revolution

artículo científico publicado en 1992

The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer

artículo científico publicado en 2016

The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2009

The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS)

artículo científico publicado en 2002

The accuracy of cancer diagnoses as reported in families with head and neck cancer: a case-control study

artículo científico publicado en 2008

The association of germ cell tumours of the testis with sarcoid-like processes

artículo científico publicado en 1992

The carrier clinic: an evaluation of a novel clinic dedicated to the follow-up of BRCA1 and BRCA2 carriers--implications for oncogenetics practice

artículo científico publicado en 2010

The clinical genetics of prostate cancer

artículo científico publicado en 2004

The contribution of rare variation to prostate cancer heritability

artículo científico publicado en 2015

The effect of sample size on polygenic hazard models for prostate cancer

artículo científico publicado en 2020

The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium

artículo científico publicado en 2015

The evolutionary history of lethal metastatic prostate cancer

artículo científico publicado en 2015

The feasibility and results of a population-based approach to evaluating prostate-specific antigen screening for prostate cancer in men with a raised familial risk

artículo científico publicado en 2006

The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators

article

The genetic epidemiology of prostate cancer and its clinical implications

artículo científico

The genetics of familial breast cancer and their practical implications

artículo científico publicado en 1994

The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.

artículo científico publicado en 1999

The incidence of breast cancer from screening women according to predicted family history risk: Does annual clinical examination add to mammography?

artículo científico publicado en 2001

The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target

artículo científico publicado en 2009

The proteomic approach to urological biomarkers.

artículo científico publicado en 2004

The psychological impact of undergoing genetic-risk profiling in men with a family history of prostate cancer

artículo científico publicado en 2015

The role of BRCA1 and BRCA2 in prostate cancer

scientific article published on 23 April 2012

The role of TP53 in breast cancer development.

artículo científico publicado en 1993

The role of genetic factors in predisposition to squamous cell cancer of the head and neck

artículo científico publicado en 1999

The role of genetic markers in the management of prostate cancer

artículo científico

The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers

artículo científico publicado en 2015

The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine

artículo científico publicado en 2010

The utility of digital rectal examination after radical radiotherapy for prostate cancer.

artículo científico publicado en 2005

The value of rapid functional assays of germline p53 status in LFS and LFL families

artículo científico publicado en 2000

Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.

artículo científico publicado en 2005

Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome

artículo científico publicado en 2004

Translating genetic risk factors for prostate cancer to the clinic: 2013 and beyond

artículo científico publicado en 2014

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study

artículo científico publicado en 2014

Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.

artículo científico publicado en 2017

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene

artículo científico publicado en 2002

Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer

scientific article published on 13 August 2020

UKCGG Consensus Group guidelines for the management of patients with constitutional TP53 pathogenic variants

artículo científico publicado en 2020

Unravelling the genetics of prostate cancer

artículo científico publicado en 2004

Unusual presentation of Lynch Syndrome

artículo científico publicado en 2009

Upfront Docetaxel in the Post-STAMPEDE World: Lessons from an Early Evaluation of Non-trial Usage in Hormone-Sensitive Prostate Cancer

artículo científico publicado en 2017

Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer Risk

artículo científico publicado en 2016

Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations

artículo científico publicado en 2016

Validation of genome-wide prostate cancer associations in men of African descent

artículo científico publicado en 2010

Validation of loci at 2q14.2 and 15q21.3 as risk factors for testicular cancer.

artículo científico publicado en 2017

Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG)

artículo científico publicado en 2011

We are talking, but are they listening? Communication patterns in families with a history of breast/ovarian cancer (HBOC).

artículo científico publicado en 2004

Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer.

artículo científico publicado en 2009

Whole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk

artículo científico publicado en 2015

gsSKAT: Rapid gene set analysis and multiple testing correction for rare-variant association studies using weighted linear kernels

artículo científico publicado en 2017

p53 therapy in a patient with Li-Fraumeni syndrome

artículo científico publicado en 2007

seXY: a tool for sex inference from genotype arrays

artículo científico publicado en 2016

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

article by David Tan et al published December 2008 in Journal of Clinical Oncology

Lista de obras de Ros Eeles

"It's all very well reading the letters in the genome, but it's a long way to being able to write": Men's interpretations of undergoing genetic profiling to determine future risk of prostate cancer

"Social separation" among women under 40 years of age diagnosed with breast cancer and carrying a BRCA1 or BRCA2 mutation

497 oral PHASE III PILOT STUDY OF DOSE ESCALATION USING CON-FORMAL RADIOTHERAPY IN PROSTATE CANCER: LONG TERM FOLLOW UP

A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer

A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry

A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer

A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics

A genetic risk score to guide age-specific, personalized prostate cancer screening

A genetic risk score to personalize prostate cancer screening, applied to population data

A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese population

A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk

A genome-wide pleiotropy scan for prostate cancer risk

A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers

A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

A paradox: urgent BRCA genetic testing

A patient with 17 primary tumours and a germ line mutation in TP53: tumour induction by adjuvant therapy?

A pilot study of compositional analysis of the breast and estimation of breast mammographic density using three-dimensional T1-weighted magnetic resonance imaging

A population-based audit of ethnicity and breast cancer risk in one general practice catchment area in North London, UK: implications for practice

A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer

A review of prostate cancer genome wide association studies (GWAS).

A review of targeted screening for prostate cancer: introducing the IMPACT study

A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact

A robust method for detecting CHK2/RAD53 mutations in genomic DNA.

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers

AA9int: SNP interaction pattern search using non-hierarchical additive model set

AIDIT and IMPACT: building research collaborations in targeted prostate cancer screening

ATM polymorphisms as risk factors for prostate cancer development

ATM protein overexpression in prostate tumors: possible role in telomere maintenance

Abstract 4836: Gene and environment interactions of height and selected candidate SNPs in prostate cancer: results from the PRACTICAL consortium

Abstract CT322: DNA repair defects and antitumor activity with PARP inhibition: TOPARP, a phase II trial of olaparib in metastatic castration resistant prostate cancer

Abstract LB-448: Genome-wide association study identifies new prostate cancer susceptibility loci

Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.

Accurate prediction of BRCA1 and BRCA2 heterozygous genotype using expression profiling after induced DNA damage

Accurate prediction of BRCA1 and BRCA2 heterozygous genotypes using expression profiling of lymphocytes after irradiation-induced DNA damage.

Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom

Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial.

African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer

Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study

Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group

Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation

Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer

An assessment of the shared allelic architecture between type II diabetes and prostate cancer

An audit of screening for familial breast cancer before 50 years in the South Thames Region – have we got it right?

An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis

An improved high throughput heteroduplex mutation detection system for screeningBRCA2 mutations?fluorescent mutation detection (F-MD)

An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

Analysis of Li–Fraumeni syndrome and Li–Fraumeni-like families for germline mutations in Bcl10

Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk

Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families

Analysis of familial male breast cancer for germline mutations in CHEK2

Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

Analysis techniques in the presence of non-proportional hazards (PH); application to an ovarian cancer RCT with long-term follow-up.

Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival

Apoptosis, ageing and cancer susceptibility.

Apparent Mendelian inheritance of breast and colorectal cancer: chance, genetic heterogeneity or a new gene?

Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data

Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels

Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study

Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers

Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study ⬇️

Association analyses identify 31 new risk loci for colorectal cancer susceptibility

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease

Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer

Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data

Association between hormonal genetic polymorphisms and early-onset prostate cancer

Association between leptin receptor gene polymorphisms and early-onset prostate cancer

Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck

Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study